Dr. Mannick is a leading expert in the mTOR and geroscience fields and has over 15 years of drug development expertise. She has led mTOR inhibitor clinical development programs both as the Co-Founder and Chief Medical Officer of resTORbio, now Adicet Bio, and as an Executive Director of the New Indications Discovery Unit at the Novartis Institutes of Biomedical Research. She previously served as Head of Research and Development at Life Biosciences and was a Medical Director at Genzyme working in multiple therapeutic areas. Prior to Genzyme she served as a faculty member at Harvard Medical School and University of Massachusetts Medical School. She received an A.B. from Harvard College and an M.D. from Harvard Medical School and completed her residency at Brigham and Women's Hospital, followed by an infectious diseases fellowship as part of the Harvard Combined Infectious Diseases Program.